Bermuda Tech Week 2019 to Celebrate Innovation and Explore Opportunities for Growth
20.8.2019 17:27:00 EEST | Business Wire | Press release
Registration is under way and filling fast for Bermuda Tech Week 2019 which will take place at the Hamilton Princess & Beach Club from October 14-18, 2019.
The programme of insightful and engaging events will explore future opportunities and challenges presented by emerging technologies such as artificial intelligence, blockchain, digital assets, insurtech and virtual reality. It will showcase Bermuda’s ongoing success in creating a welcoming, stable and well-regulated environment where technology and start-up companies can thrive.
“Bermuda has a long history of innovation so we understand and recognise the power of technology to positively impact both the economy and society,” said Bermuda Premier David Burt. “Over the past two years, we have built on our strength as a global leader in regulating the risks associated with the global insurance industry to develop a clear regulatory framework around managing the risks associated with Fintech. Our progressive approach has drawn accolades in U.S. Senate hearings and from an SEC commissioner in providing the kind of guidance, oversight and clarity needed for the industry to deliver on its mission to make financial services more accessible to people around the globe. Being at the forefront of innovation will help drive economic growth and job creation so we remain committed to being at the forefront of emerging trends, which is why we look forward to hosting Bermuda Tech Week 2019 in October.”
Andy Burrows, CEO of the Bermuda Business Development Agency (BDA), said: “Bermuda Tech Week 2019 comes at an ideal time and builds on the momentum we have seen in the market, driven by new and innovative legislation. Industry, government and regulatory authorities here in Bermuda work closely together to deliver an environment that facilitates progress. This is reflected in the programme of events that our team has put together. Our aim is for all attendees to come away with a better knowledge of how new technologies can be deployed to drive efficiencies in business and, importantly, what Bermuda has to offer the global market as a domicile of choice for tech companies and start-ups.”
At the heart of Bermuda Tech Week 2019 is the Bermuda Tech Summit which will take place on Wednesday, October 16 under the theme ‘Focused on the Future’. Bermuda’s Premier, David Burt, is set to deliver an opening address. Hosted by the BDA, in partnership with FinTech Bermuda, the all-day summit is free to attend and will explore the transformational impact of technology on investment and business models in a wide range of industry sectors relevant to Bermuda, from hospitality and financial services to telecommunications and insurance. Attendees will gain an in-depth understanding of how Bermuda’s business environment is facilitating innovation.
Events throughout the week will feature an array of speakers and attendees from across Bermuda’s government, industry and regulatory authorities along with some of the world’s most dynamic technology companies, including BitMEX, Blade, ChainThat, Circle, Data Innovation Labs, Flyt, Muckr.ai, SeaHeal, The Giving Block, Uulala, X and XBTO. Leading hotel brands AccorHotels (Fairmont), Hilton, Marriott International and Wyndham Hotel Group will also participate.
The schedule for Bermuda Tech Week 2019 includes:
- Liquidity Summit – a fintech event focused on leading and emerging trends across the world of finance. Presented by Hub Culture and the Ven digital currency, this event will take place on Monday, October 14 and Tuesday, October 15
- Defend and Detect – a technology and technique event hosted by KPMG Bermuda showcasing how technology and business ideas can come together to solve complex challenges in managing regulatory risk and compliance. This event is invitation-only and will take place on Tuesday, October 15
- Hello World – the world’s first AI to AI event hosted by Zeke.ai, Hub Culture’s emergent intelligent machine. This event will take place on Thursday, October 17
- Tech Beach ‘FinTech Innovation Island’ – coming to Bermuda for the first time, this will be an innovative space to explore opportunities for collaboration. Presented by Tech Beach, in partnership with the BDA and the Bermuda Tourism Authority (BTA), this event will be held on Thursday, October 17 and Friday, October 18
To register for events, visit www.bermudatechweek.bm, or if your company is interested in sponsoring or hosting additional events throughout the week, contact bermudatechweek@bda.bm. For a limited period only, take advantage of the $250/night preferred room rate at the Hamilton Princess & Beach Club by clicking here.
CONNECTING BUSINESS
The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190820005544/en/
Contact information
Nicola Stevens
nstevens@bda.bm
+1 441 292 7774
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
